CRDF icon

Cardiff Oncology
CRDF

Overview Fund Activity

21 hedge funds and large institutions have $1.11M invested in Cardiff Oncology in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 10 closing their positions.

Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$601K
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$77K
3
ARTA
3
A.R.T. Advisors
New York
$70K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$254K
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$10K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
EP
2
Elkhorn Partners
Nebraska
$0
3
DY
3
Dowling & Yahnke
California
$0
4
UBS Group
4
UBS Group
Switzerland
$3K
5
SNB
5
Security National Bank
Nebraska
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
CFA
27
Carroll Financial Associates
North Carolina
$0 21 – –
AG
28
Advisor Group
Arizona
$0 20 – –
Northwestern Mutual Wealth Management
29
Northwestern Mutual Wealth Management
Wisconsin
$0 48 +1 +2%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 1 +1 New
FRA
31
Front Row Advisors
California
$0 2 +2 New
Morgan Stanley
32
Morgan Stanley
New York
$0 103 +6 +6%
WAM
33
Wealthspire Advisors (Maryland)
Maryland
$0 24 +24 New
1
2